Yıl: 2020 Cilt: 12 Sayı: 2 Sayfa Aralığı: 182 - 194 Metin Dili: Türkçe DOI: 10.18863/pgy.548052 İndeks Tarihi: 30-11-2021

Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu

Öz:
Dikkat eksikliği hiperaktivite bozukluğu (DEHB), kalıtsal olarak geçebilen, çevresel faktörlerden etkilenen, çocukluk çağının en yaygın görülen nöropsikiyatrik sendromu olup, yetişkin çağda da devam edebilen ve hatta geriatrik popülasyonda görülebilen bir bozukluktur. Geriatrik popülasyonda kendini farklı semptomlarla gösterebilen, tanısı genelde göz ardı edilen DEHB, kimi zaman kendini demans ya da depresyon belirtileri ile de gösterebilmektedir. Yaşlı popülasyonda prevalansın %3-4 oranında olduğu düşünülmektedir. Henüz yaşlılaraözgül DEHB tanı ölçütleri mevcut olmamakla birlikte DSM-5’de bulunan ölçütlerdenyararlanılarak tanı konulmaktadır. Görüntüleme ve nörofizyolojik yöntemlerden yararlanılsa da DEHB’ye yönelik özgül bir bulgu ya da görüntü yoktur. Frontal ve prefrontal alanlarda, gri cevher lezyonlarında bozukluklar manyetik rezonans görüntüleme (MRI) ile gösterilebilmektedir. DEHB patofizyolojisi tam olarak aydınlatılamamış olsa da geriatrik popülasyonda uyku bozukluklarından demansa kadar uzanan geniş bir spektrumda klinik özellikler gözlenmektedir. Dolayısıyla yaşlı bireylerde DEHB ayrıntılı bir şekilde incelenmeli ve yeni çalışmalarla hastalığa özgül tanı ölçütleri geliştirilmelidir çünkü mevcut literatürde belirtilen DEHB sıklığının gerçek yaşamdakinden çok daha az olduğu düşünülmektedir.
Anahtar Kelime:

Attention Deficit Hyperactivity Disorder in the Elderly

Öz:
Attention deficit hyperactivity disorder (ADHD) is a neuropsychiatric syndrome which is hereditarily inherited, affected by environmental factors, and most commonly seen in childhood. It is a disorder that can continue in adulthood and is seen even in the geriatric population. ADHD, which may manifest itself with different symptoms in the geriatric population and the diagnosis of which is often overlooked, may sometimes present itself with dementia or depressive symptoms. Its prevalence is thought to be 3-4% in the elderly population. However, the diagnostic criteria of the ADHD in elderly population are not yet available and the diagnosis is made based on the criteria found in the DSM-5 (Diagnostic and Statistical Manual of Mental Health Disorders, 5th edition). Although some imaging and neurophysiological methods are utilized, there is no specific finding or image for ADHD. Defects in gray matter lesions in frontal and prefrontal areas can be demonstrated by magnetic resonance imaging (MRI). Some researchers think that functional MRI will provide more promising results in the future. Although the pathophysiology of ADHD has not yet been fully elucidated, clinical features are observed in a wide spectrum ranging from sleep disorders to dementia in the geriatric population. Therefore, ADHD should be examined in detail in the elderly population and new diagnostic criteria should be developed for the disorder by new studies. Because it is thought that the frequency of ADHD in the current literature is much less than that in real life.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Adler L, Wilens T, Zhang S, Durell T, Walker D, Schuh L (2009). Retrospective safety analysis of atomoxetine in adult ADHD patients with or without comorbid alcohol abuse and dependence. Am J Addict, 18:393-401.
  • APA (1968) Diagnostic and Statistical Manual of Mental Health Disorders, 2th edition (DSM-II). Washington DC, American Psychiatric Association.
  • APA (1978) Diagnostic and Statistical Manual of Mental Health Disorders, 3th edition (DSM-III). Washington DC, American Psychiatric Association.
  • APA (1987) Diagnostic and Statistical Manual of Mental Health Disorders, 3th edition (DSM-III-R). Washington DC, American Psychiatric Association.
  • APA (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV-TR). Washington DC, American Psychiatric Association.
  • APA (2013) Diagnostic and Statistical Manual of Mental disorders, 5th edition (DSM-5). Washington DC, American Psychiatric Association.
  • Bolea-Alamanac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D et al. (2014) Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol, 28:179–203.
  • Brod M, Schmitt E, Goodwin M, Hodgkins P, Niebler G (2012) ADHD burden of illness in older adults: a life course perspective. Qual Life Res, 21:795-799.
  • Butterfield ME, Saal J, Young B, Young JL (2016) Supplementary guanfacine hydrochloride as a treatment of attention deficit hyperactivity disorder in adults: a double blind, placebo-controlled study. Psychiatry Res, 236:136-141.
  • Casey B, Epstein JN, Buhle J, Liston C, Davidson MC,Tonev ST et al. (2007) Frontostriatal connectivity and its role in cognitive control in parent-child dyads with ADHD. AM J Psychiatry, 164:1729-1736.
  • Castellanos FX, Lee PP, Sharp W, Jeffrie NO, Greenstein DK, Clasen SL et al. (2002) Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA, 288:1740-1748.
  • Chang Z, Lichtenstein P, D’onofrio BM, Sjölander A, Larsson H (2014) Serious transport accidents in adults with attentiondeficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry, 71:319-325.
  • Chang F, O’Hare AM, Miao Y, Steinman MA (2015) Use of renally inappropriate medications in older veterans: a national study. J Am Geriatr Soc,63:2290-2297.
  • Chang Z, D’Onofrio BM, Quinn PD, Lichtenstein P, Larsson H (2016) Medication for attention-deficit/hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study. Biol Psychiatry, 80:916-922.
  • Chen Q, Sjölander A, Runeson B, D’onofrio BM, Lichtenstein P, Larsson H (2014) Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study. BMJ, 348: g3769.
  • Cubillo A, Rubia K (2010) Structural and functional brain imaging in adult attention-deficit/hyperactivity disorder. Expert Rev Neurother, 10:603-620.
  • Cubillo A, Halari R, Smith A, Giampietro V, Taylor E, Rubia K (2012) Fronto-cortical and fronto-subcortical brain abnormalities in children and adults with ADHD: a review and evidence for fronto-striatal dysfunctions in adults with ADHD followed up from childhood during motivation and attention. Cortex, 48:194-215.
  • Donfrancesco R, Nativio P, Di Benedetto A, Villa MP, Andriola E, Melegari MG et al. (2016) Anti-Yo antibodies in children with ADHD: first results about serum cytokines. J Atten Disord, 1087054716643387.
  • Ellison WI, Ellison WZ, Bullmore E (2008) Structural brain change in attention deficit hyperactivity disorder identified by metaanalysis. BMC Psychiatry, 8:51.
  • Faraone SV (2000) Genetics of childhood disorders: XX. ADHD, part 4: is ADHD genetically heterogeneous? J Am Acad Child Psychiatry, 39:1455-1457.
  • Faraone SV, Biederman J, Mick E (2006) The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med, 36:159-165.
  • Faraone SV, Glatt SJ (2010) A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry, 71:754-763.
  • Fassbender C, Zhang H, Buzy WM, Cortes RC, Mizuiri D, Beckett L et al. (2009) A lack of default network suppression is linked to increased distractibility in ADHD. Brain Res, 1273:114-128.
  • Fayyad J, Sampson NA, Hwang I, Adamowski T, Gaxiola S, Al-Hamzawi A et al. (2017) The descriptive epidemiology of DSM-IV adult ADHD in the world health organization world mental health surveys. Atten Defic Hyperact Disord, 9:47-65.
  • Fischer BL, Gunter HG, Steinhafel CH, Howell T (2012) The identification and assessment of late-life ADHD in memory clinics. J Atten Disord, 16:333-338. Frodl T, Skokauskas, N (2012) Meta‐analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand, 125(2):114-126.
  • Fusar-Poli P, Rubia K, Rossi G, Sartori G, Balottin U (2012) Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis. Am J Psychiatry, 169:264-272.
  • Ghanizadeh A (2015) A systematic review of reboxetine for treating patients with attention deficit hyperactivity disorder. Nord J Psychiatry, 69:241-248. Gizer IR, Ficks C, Waldman ID (2009) Candidate gene studies of ADHD: a meta-analytic review. Hum Genet, 126:51-90.
  • Golimstok A, Rojas J, Romano M, Zurru M, Doctorovich D, Cristiano E (2011) Previous adult attention‐deficit and hyperactivity disorder symptoms and risk of dementia with Lewy bodies: a case–control study. Eur J Neurol, 18:78-84.
  • Guldberg KT, Johansson B (2009) Old people reporting childhood AD/HD symptoms: Retrospectively self-rated AD/HD symptoms in a population-based Swedish sample aged 65–80. Nord J Psychiatry, 63:375-382.
  • Henry E, Hill JS (2011) Experiences of older adult women diagnosed with attention deficit hyperactivity disorder. J Women Aging, 23:246-262.
  • Hoogman M, Bralten J, Hibar PD, Mennes M, Zwiers MP, Schweren L et al. (2011) Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. Lancet Psychiatry, 4:310-319.
  • Jain R, Segal S, Kollins SH, Khayrallah M (2011) Clonidine extended-release tablets for pediatric patients with attentiondeficit/hyperactivity disorder. J Am Acad Child Psychiatry, 50:171-179.
  • Kendall T, Taylor E, Perez A, (2008) Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. BMJ, 337:a1239.
  • Kollins SH, Jain R, Brams M, Segal S, Findling RL, Wigal SB et al. (2011) Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics, 127:1406-1413.
  • Kooij JJS, Burger H, Boonstra A, Van Der Linden D, Kalma LE, Buitelaar JK (2004) Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychol Med, 34:973–982.
  • Kooij JJS, Michielsen M, Kruithof H, Bijlenga D (2016) ADHD in old age: a review of the literature and proposal for assessment and treatment. Expert Rev Neurother, 16:1371-1381.
  • Kooij JJS, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balázs J et al. (2019) Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry, 56:14-34.
  • Kozłowska A, Wojtacha P, Równiak M, Kolenkiewicz M, Huang A (2019) ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats. Psychopharmacology(Berl),236:2937-2958.
  • Krause J (2008) SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev Neurother, 8:611-625.
  • Lange KW, Reichl S, Lange KM, Tucha L, Tucha O (2010) The history of attention deficit hyperactivity disorder. Atten Defic Hyperact Disord, 2:241-255.
  • Liu Y,Wang Y (2002) Cognitive functions of children with attention deficit/ hyperactivity disorder. Zhonghua Yi Xue Za Zhi 82:389–392.
  • Luna B, Padmanabhan A, O’Hearn K (2010) What has fMRI told us about the development of cognitive control through adolescence? Brain Cogn, 72:101-113.
  • Martel MM, Klump K, Nigg JT, Breedlove SM, Sisk CL (2009). Potential hormonal mechanisms of attention-deficit/hyperactivity disorder and major depressive disorder: a new perspective. Horm Behav, 55:465-479.
  • Maneeton N, Maneeton B, Srisurapanont M, Martin SD (2011) Bupropion for adults with attention‐deficit hyperactivity disorder: Meta‐analysis of randomized, placebo-controlled trials. Psychiatry Clin Neurosci, 65:611-617.
  • Michielsen M, Semeijn E, Comijs HC, Van de Ven P, Beekman AT, Deeg DJH et al. (2012) Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands. Br J Psychiatry, 201:298-305.
  • Michielsen M, Comijs HC, Semeijn EJ, Beekman AT, Deeg DJ, Kooij JJS (2013) The comorbidity of anxiety and depressive symptoms in older adults with attention-deficit/hyperactivity disorder: a longitudinal study. J Affect Disord, 148:220-227.
  • Mittleman BB, Castellanos FX, Jacobsen LK, Rapoport JL, Swedo, SE, Shearer GM (1997) Cerebrospinal fluid cytokines in pediatric neuropsychiatricdisease. J Immunol, 159:2994 -2999.
  • Nakao T, Radua J, Rubia K, Mataix-Cols D (2011) Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am J Psychiatry, 168:1154-1163.
  • Oades RD, Dauvermann MR, Schimmelmann BG, Schwarz MJ, Myint AM (2010) Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism-effects of medication. Behav Brain Funct, 6:29.
  • Ormhøj SS, Pottegård A, Gasse C, Rasmussen L (2018) Use of attention‐deficit/hyperactivity disorder medication among older adults in Denmark. Br J Clin Pharmacol, 84:1505-1513.
  • Purves-Tyson TD, Owens SJ, Double KL, Desai R, Handelsman DJ, Weickert CS (2014) Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathway. PLoS One, 9:e91151.
  • Riahi F, Tehrani DM, Shahrivar Z, Alaghband RJ (2010) Efficacy of reboxetine in adults with attention‐deficit/hyperactivity disorder: A randomized, placebo‐controlled clinical trial. Psychopharm Clin, 25:570-576.
  • Roberts BA, Martel MM (2013) Prenatal testosterone and preschool disruptive behavior disorders. Pers Individ Diff, 55:962–966.
  • Romanos M,Weise D, Schliesser M, Schecklmann M, Löffler J,Warnke A et al. (2010) Structural abnormality of the substantia nigra in children with attention-deficit hyperactivity disorder. J Psychiatry Neurosci, 35:55–58.
  • Rosazza C, Minati L (2011) Resting-state brain networks: literature review and clinical applications. Neurol Sci, 32:773-785.
  • Schneider M, Retz W, Coogan A, Thome J, Rösler M (2006) Anatomical and functional brain imaging in adult attentiondeficit/hyperactivity disorder (ADHD) a neurological view. Eur Arch PsychiatryClin Neurosci, 256:32-41.
  • Senol V, Unalan D, Akca RP, Basturk M (2018) Prevalence of attention-deficit/hyperactivity and other disruptive behaviour disorder symptoms among primary school-age children in Kayseri, Turkey. J Int Med Res, 46:122-134.
  • Seixas M, Weiss M, Muller U (2012) Systematic review of national and international guidelines on attention-deficit hyperactivity disorder. J Psychopharmacol, 26:753–765.
  • Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch J, Greenstein D et al. (2017) Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A, 4:19649-19654.
  • Simon V, Czobor P, Bálint S, Mészáros A, Bitter I (2009) Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry, 194:204-211.
  • Snyder SM, Hall JR (2006) A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. J Clin Neurophysiol, 23:441-456.
  • Sokunbi MO, Fung W, Sawlani V, Choppin S, Linden DE, Thome J (2013) Resting state fMRI entropy probes complexity of brain activity in adults with ADHD. Psychiatry Res, 214:341-348.
  • Sowell ER, Thompson PM, Toga AW (2004) Mapping changes in the human cortex throughout the span of life. Neurol Sci, 10:372- 392.
  • Springer R (2018) ADHD: The lifespan and effects from adolescence through adulthood (Dissertation). Murray, Murray State University. Stefanatos GA, Baron IS (2017) Attention-deficit/hyperactivity disorder: A neuropsychological perspective towards DSM-V. Neuropsychol Rev, 17:5-38.
  • Surman CB, Goodman DW (2017) Is ADHD a valid diagnosis in older adults? Atten Defic Hyperact Disord, 9:161-168.
  • Tannock R (1998) Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry, 39:65-99.
  • Wetzel M, Burke W (2008) Addressing attention-deficit/hyperactivity disorder in later adulthood. Clin Geriatr, 16:33-39.
  • Wolf RC, Plichta MM, Sambataro F, Fallgatter AJ, Jacob C, Lesch KP et al. (2009) Regional brain activation changes and abnormal functional connectivity of the ventrolateral prefrontal cortex during working memory processing in adults with attention‐ deficit/hyperactivity disorder. Hum Brain Mapp, 30:2252-2266.
  • Yener S (2017) Dikkat eksikliği-hiperaktivite bozukluğu yaraticiliği tetikler mi? Psikolojik iklimin aracı rolü. Sinop Üniversitesi Sosyal Bilimler Dergisi, 1:115-148.
APA Cavusoglu C, Demirkol M, Tamam L (2020). Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu. , 182 - 194. 10.18863/pgy.548052
Chicago Cavusoglu Cagatay,Demirkol Mehmet Emin,Tamam Lut Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu. (2020): 182 - 194. 10.18863/pgy.548052
MLA Cavusoglu Cagatay,Demirkol Mehmet Emin,Tamam Lut Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu. , 2020, ss.182 - 194. 10.18863/pgy.548052
AMA Cavusoglu C,Demirkol M,Tamam L Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu. . 2020; 182 - 194. 10.18863/pgy.548052
Vancouver Cavusoglu C,Demirkol M,Tamam L Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu. . 2020; 182 - 194. 10.18863/pgy.548052
IEEE Cavusoglu C,Demirkol M,Tamam L "Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu." , ss.182 - 194, 2020. 10.18863/pgy.548052
ISNAD Cavusoglu, Cagatay vd. "Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu". (2020), 182-194. https://doi.org/10.18863/pgy.548052
APA Cavusoglu C, Demirkol M, Tamam L (2020). Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu. Psikiyatride Güncel Yaklaşımlar, 12(2), 182 - 194. 10.18863/pgy.548052
Chicago Cavusoglu Cagatay,Demirkol Mehmet Emin,Tamam Lut Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu. Psikiyatride Güncel Yaklaşımlar 12, no.2 (2020): 182 - 194. 10.18863/pgy.548052
MLA Cavusoglu Cagatay,Demirkol Mehmet Emin,Tamam Lut Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu. Psikiyatride Güncel Yaklaşımlar, vol.12, no.2, 2020, ss.182 - 194. 10.18863/pgy.548052
AMA Cavusoglu C,Demirkol M,Tamam L Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu. Psikiyatride Güncel Yaklaşımlar. 2020; 12(2): 182 - 194. 10.18863/pgy.548052
Vancouver Cavusoglu C,Demirkol M,Tamam L Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu. Psikiyatride Güncel Yaklaşımlar. 2020; 12(2): 182 - 194. 10.18863/pgy.548052
IEEE Cavusoglu C,Demirkol M,Tamam L "Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu." Psikiyatride Güncel Yaklaşımlar, 12, ss.182 - 194, 2020. 10.18863/pgy.548052
ISNAD Cavusoglu, Cagatay vd. "Yaşlılarda Dikkat Eksikliği ve Hiperaktivite Bozukluğu". Psikiyatride Güncel Yaklaşımlar 12/2 (2020), 182-194. https://doi.org/10.18863/pgy.548052